Citation tools
"PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced pulmonary fibrosis by inhibition of multiple pro-inflammatory/fibrotic key mediators." European Respiratory Journal
42.Suppl 57
(2013):
P4745.
Web. 23 April. 2024.